Karadag O, Farisogullari B, Yagiz B, Erden A, et al. Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure Registry. Clin Exp Rheumatol 2023 Aug 29. doi: 10.55563.
PMID: 37650346